Drug Shortage Report for ERWINASE
| Report ID | 22112 |
| Drug Identification Number | 02237815 |
| Brand name | ERWINASE |
| Common or Proper name | Erwina L-asparaginase |
| Company Name | JAZZ PHARMACEUTICALS FRANCE SAS |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ASPARAGINASE |
| Strength(s) | 10000UNIT |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 3 mL vials, 5 vials per carton |
| ATC code | L01XX |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2017-09-14 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | 2021-03-10 |
| Shortage status | Resolved |
| Updated date | 2021-03-16 |
| Company comments | Reason for ongoing shortage in Canada (less than 3-months supply) due to global capacity constraints in manufacturing leading to just-in time supply with intermittent shortages. Additionally demand has increased. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 84 QUAI CHARLES DE GAULLE CITY ONE LYON, AUVERGNE-RHONE-ALPES FRANCE 69006 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2021-03-16 | French | Compare |
| v8 | 2021-03-16 | English | Compare |
| v7 | 2018-02-21 | French | Compare |
| v6 | 2018-02-21 | English | Compare |
| v5 | 2018-02-21 | English | Compare |
| v4 | 2017-09-15 | English | Compare |
| v3 | 2017-09-14 | French | Compare |
| v2 | 2017-09-14 | English | Compare |
| v1 | 2017-09-14 | English | Compare |
Showing 1 to 9 of 9